Abstract
The impact of SNPs and other molecular diagnostic markers is now being felt--this will grow as
more molecular markers are validated and launched for their diagnostic and prognostic value.
This report analyzes the technologies and their impact in the molecular diagnostics marketplace.
We present an assessment of all the technologies of value in this space and which market segments
are impacted and affected by these technologies.
Furthermore, in this report are presented qualitative and quantitative market analysis of the
molecular diagnostics space. We present total industry revenues, growth rates, and the various
qualitative drivers that are contributing to the growth of the marketplace.